COVID-19 rapid guideline: managing COVID-19 (NG191)Product type:GuidanceProgramme:NICE guidelineLast updated: 8 May 2024Published: 23 March 2021
Nirmatrelvir plus ritonavir, sotrovimab and tocilizumab for treating COVID-19 (TA878)Product type:GuidanceProgramme:Technology appraisal guidanceLast updated: 13 March 2024Published: 29 March 2023
COVID-19 rapid guideline: managing the long-term effects of COVID-19 (NG188)Product type:GuidanceProgramme:NICE guidelineLast updated: 25 January 2024Published: 18 December 2020